U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

ALys amyloidosis

MedGen UID:
1842307
Concept ID:
C5680270
Disease or Syndrome
Synonyms: Familial amyloid nephropathy due to lysozyme variant; familial amyloid nephropathy due to lysozyme variant; Familial renal amyloidosis due to lysozyme variant; familial renal amyloidosis due to lysozyme variant; hereditary amyloid nephropathy due to lysozyme variant; Hereditary amyloid nephropathy due to lysozyme variant; Hereditary renal amyloidosis due to lysozyme variant; hereditary renal amyloidosis due to lysozyme variant; Lysozyme amyloidosis; lysozyme amyloidosis
Modes of inheritance:
Autosomal dominant inheritance
MedGen UID:
141047
Concept ID:
C0443147
Intellectual Product
Source: Orphanet
A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele.
 
Monarch Initiative: MONDO:0019732
Orphanet: ORPHA93561

Definition

A rare, hereditary amyloidosis with primary renal involvement characterized by amyloid deposition in the kidney glomeruli and medulla, gastrointestinal tract, liver, spleen and slow disease progression. Symptoms and signs include nausea, vomiting, dyspepsia, gastritis, gastrointestinal hemorrhage, abdominal pain, hepatic rupture, sicca syndrome, purpura and petechiae, lymphadenopathy and renal dysfunction. [from ORDO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVALys amyloidosis

Recent clinical studies

Prognosis

Anker S, Hinderhofer K, Baur J, Haupt C, Röcken C, Beimler J, Zeier M, Weiler M, Wühl E, Kimmich C, Schönland S, Hegenbart U
Amyloid 2022 Dec;29(4):245-254. Epub 2022 May 9 doi: 10.1080/13506129.2022.2072198. PMID: 35533055

Clinical prediction guides

Anker S, Hinderhofer K, Baur J, Haupt C, Röcken C, Beimler J, Zeier M, Weiler M, Wühl E, Kimmich C, Schönland S, Hegenbart U
Amyloid 2022 Dec;29(4):245-254. Epub 2022 May 9 doi: 10.1080/13506129.2022.2072198. PMID: 35533055

Supplemental Content

Table of contents

    Clinical resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...